Fingerprint Dive into the research topics of 'CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder
Chihiro Namatame, Tatsuro Misu, Yoshiki Takai, Shuhei Nishiyama, Ichiro Nakashima, Kazuo Fujihara, Masashi Aoki
Research output: Contribution to journal › Article › peer-review